Polycystic ovary syndrome
Conditions
Interventions
control group-Basic treatment group 2:Lifestyle intervention+oral contraceptive pills (drospirenone ethinylestradiol tablets II)
control group-Basic treatment group 1:Lifestyle intervention+oral metformin
Treatment Group 1:Lifestyle intervention+oral metformin+Qiyin granules
Treatment Group 2:Lifestyle intervention+oral contraceptive pills (drospirenone ethinylestradiol tablets II)+Qiyin granules
Sponsors
The Affiliated Traditional Chinese Medicine Hospital of Xinjiang Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria -Age: Female aged 18-40 -Meets the diagnostic criteria for PCOS -Meets MAFLD diagnostic criteria -Consistent with the traditional Chinese medicine liver depression and spleen deficiency syndrome type -Individuals without a history of relevant medication treatment in the past 3 months -Informed consent and willingness to participate in the study as well as signing the informed consent form
Exclusion criteria
Exclusion criteria: Exclusion criteria -Pregnant preparing for pregnancy or breastfeeding women -Diseases that affect ovulation function such as premature ovarian failure thyroid disease hyperprolactinemia hypogonadism etc -Individuals with severe heart liver kidney dysfunction and serious hematological disorders -Diseases that may lead to fatty liver include drug-induced fatty liver malnutrition and Wilson's disease -Individuals allergic to the experimental drug -Severe mental illness patients -Patients with prohibited estrogen and progesterone related diseases such as estrogen and progesterone dependent tumors; -Individuals with a history of smoking thrombosis etc. are contraindicated for taking Yousiyue orally. -Patients with incomplete data or follow-up. -Patients who have received other experimental treatments in the past that may affect the results.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Liver function;Hormone levels; | — |
Secondary
| Measure | Time frame |
|---|---|
| FibroScan-FAST(FAST);Metabolic indicators; | — |
Countries
China
Contacts
Public ContactWanLi
The Affiliated Traditional Chinese Medicine Hospital of Xinjiang Medical University
Outcome results
None listed